A colon cancer-based study reported that the inhibitory effects of formononetin were related with STAT3 and phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) signaling pathways [11] (Table 1). This evidence concerns the gene AKT1 and colonic neoplasm.